Data / Form D filings / bioVidria, Inc.
bioVidria, Inc.: Form D filings
bioVidria, Inc., a biotechnology company in Tucson, AZ, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on July 1, 2010, reports $150,000 sold of a $375,000 offering to 3 investors.
Find out what bioVidria, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9040 S. RITA ROAD, SUITE 1100, Tucson, AZ, 85747
- Phone
- (520) 665-1956
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1471003
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2010 | New notice | $375,000 | $150,000 | $225,000 | 3 | Jun 7, 2010 | sec.gov |
| Sep 2, 2009 | New notice | $200,000 | $200,000 | $0 | 9 | Aug 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Albert P Statham | Executive Officer, Director | |
| Gabriel J Longoria | Director | |
| Mary J Wirth | Executive Officer, Director | |
| Kirt J Gardner | Director | |
| Corey M Smith | Executive Officer, Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Jun 28, 2010 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what bioVidria, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.